The acute respiratory distress syndrome
Open accessThe DOI matches its Crossref record; 155 of the 155 references it cites were found in a registry or an index.
Abstract
The acute respiratory distress syndrome (ARDS) is an important cause of acute respiratory failure that is often associated with multiple organ failure. Several clinical disorders can precipitate ARDS, including pneumonia, sepsis, aspiration of gastric contents, and major trauma. Physiologically, ARDS is characterized by increased permeability pulmonary edema, severe arterial hypoxemia, and impaired carbon dioxide excretion. Based on both experimental and clinical studies, progress has been made in understanding the mechanisms responsible for the pathogenesis and the resolution of lung injury, including the contribution of environmental and genetic factors. Improved survival has been achieved with the use of lung-protective ventilation. Future progress will depend on developing novel therapeutics that can facilitate and enhance lung repair.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In its most extreme manifestation (207), acute lung injury presents with or evolves into acute respiratory distress syndrome.”
From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [207]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Evidence for Human Lung Stem Cells
Kajstura, J., Rota, M., Hall, S. R., Hosoda, T., D'Amario, D., Sanada, F., Zheng, H., Ogórek, B., Rondon-Clavo, C., Ferreira-Martins, J., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1101324 · Cited by 380
Retracted(2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421801 · Cited by 12,941
Acute Respiratory Distress Syndrome: The Berlin Definition
(2012) · JAMA · doi:10.1001/jama.2012.5669 · Cited by 8,731
Bernard, G. R., Artigas, A., Brigham, K. L., Carlet, J., Falke, K., Hudson, L., Lamy, M., Legall, J. R., Morris, A., & Spragg, R. (1994) · American journal of respiratory and critical care medicine · doi:10.1164/ajrccm.149.3.7509706 · Cited by 6,746
The Acute Respiratory Distress Syndrome
Matthay, M. A. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605303342209 · Cited by 4,923
Self-citationThe Acute Respiratory Distress Syndrome
Ware, L. B., & Matthay, M. A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421806 · Cited by 4,666
Self-citationACUTE RESPIRATORY DISTRESS IN ADULTS
Ashbaugh, D., Boyd Bigelow, D., Petty, T., & Levine, B. (1967) · The Lancet · doi:10.1016/s0140-6736(67)90168-7 · Cited by 4,278
Incidence and Outcomes of Acute Lung Injury
Rubenfeld, G. D., Caldwell, E., Peabody, E., Weaver, J., Martin, D. P., Neff, M., Stern, E. J., & Hudson, L. D. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050333 · Cited by 3,684
Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome.
Amato, M. B. P., Barbas, C. S. V., Medeiros, D. M., Magaldi, R. B., Schettino, G. P., Lorenzi-Filho, G., Kairalla, R. A., Deheinzelin, D., Munoz, C., Oliveira, R., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802053380602 · Cited by 3,654
Comparison of Two Fluid-Management Strategies in Acute Lung Injury
(2006) · New England Journal of Medicine · doi:10.1056/nejmoa062200 · Cited by 3,538
Research works printed but not linked: 6
- 2012, JAMA., 307, 2526
- Liu, 2007, Crit Care Med., 35, 2755, 10.1097/01.CCM.0000291649.72238.6D · doi:10.1097/01.ccm.0000291649.72238.6d · Paper page
- Looney, 2009, J Clin Invest., 119, 3450
- Camerer, 2009, J Clin Invest., 119, 1871
- Adamson, 1974, Lab Invest., 30, 35
- Webb, 1974, Am Rev Respir Dis., 110, 556
Cited by
Items 501–600 of 1,000
Ma, H., Feng, X., & Ding, S. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.11.038 · Cited by 43
“…injury (ALI) is characterized by severe hypoxemia, pulmonary edema, and neutrophil accumulation in the lung tissue, is a common clinical problem associated with significant morbidity and mortality in some emergency infectious diseases (Matthay et al., 2012; Rubenfeld, 2003; Zhang et al., 2009).”
BackgroundMeliopoulos, V. A., Van de Velde, L.-A., Van de Velde, N. C., Karlsson, E. A., Neale, G., Vogel, P., Guy, C., Sharma, S., Duan, S., Surman, S. L., et al. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005804 · Cited by 42
Bello, G., & Blanco, P. (2018) · Journal of Ultrasound in Medicine · doi:10.1002/jum.14671 · Cited by 48
Luo, Q., Zhu, J., Zhang, Q., Xie, J., Yi, C., & Li, T. (2020) · Inflammation · doi:10.1007/s10753-020-01183-3 · Cited by 41
Sukkar, S. G., & Bassetti, M. (2020) · Nutrition · doi:10.1016/j.nut.2020.110967 · Cited by 45
“A possible clinical solution that reduces the activity of M1 macrophages in the early stages of inflammation could be to target their metabolic specificity [9,10,15].”
InfluentialZayed, M., & Iohara, K. (2020) · Cell Transplantation · doi:10.1177/0963689720952089 · Cited by 43
Wang, Y., Wu, Y., Zhang, J.-Z., Tang, J.-H., Fan, R., Li, F., Yu, B., Kou, J., & Zhang, Y. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-00502-6 · Cited by 46
Lecuona, E., Sun, H., Chen, J., Bittar, H. E. T., Baker, M. A., & Sznajder, J. I. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0373oc · Cited by 42
Wang, Q., Yan, S.-F., Yu, H., & Jin, S. (2018) · Chinese Medical Journal · doi:10.4103/0366-6999.229890 · Cited by 45
Zhu, C., Xie, J., Zhao, Z., Li, P., Liu, Q., Guo, Y., Meng, Y., Wan, X., Bian, J., Deng, X., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.949217 · Cited by 49
Qiao, X., Kashiouris, M. G., L'Heureux, M., Fisher, B. J., Leichtle, S. W., Truwit, J. D., Nanchal, R. S., Hite, R. D., Morris, P. E., Martin, G. S., et al. (2022) · Nutrients · doi:10.3390/nu14204415 · Cited by 48
Ming, K., Zhuang, S., Ma, N., Nan, S., Li, Q., Ding, M., & Ding, Y. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1033875 · Cited by 46
Bosmann, M., Grailer, J. J., Russkamp, N. F., Ruemmler, R., Zetoune, F. S., Sarma, J. V., & Ward, P. A. (2013) · Shock · doi:10.1097/shk.0b013e31828f9c92 · Cited by 46
Barnett, N., Zhao, Z., Koyama, T., Janz, D. R., Wang, C.-Y., May, A. K., Bernard, G. R., & Ware, L. B. (2014) · Annals of Intensive Care · doi:10.1186/2110-5820-4-5 · Cited by 41
“It is still not understood why some but not all patients at risk develop ALI/ARDS [24].”
BackgroundSelf-citationCellular Therapies in Trauma and Critical Care Medicine: Forging New Frontiers
Pati, S., Pilia, M., Grimsley, J. M., Karanikas, A. T., Oyeniyi, B. T., Holcomb, J. B., Cap, A. P., & Rasmussen, T. E. (2015) · Shock · doi:10.1097/shk.0000000000000482 · Cited by 43
Incidence and recognition of acute respiratory distress syndrome in a UK intensive care unit
Summers, C., Singh, N., Worpole, L., Simmonds, R. P., Babar, J. L., Condliffe, A. M., Gunning, K. E. J., Johnston, A. J., & Chilvers, E. R. (2016) · Thorax · doi:10.1136/thoraxjnl-2016-208402 · Cited by 41
Gao, Y., Zhang, H., Luo, L., Lin, J., Li, D., Zheng, S., Huang, H., Yan, S.-F., Yang, J., Yu, H., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700315 · Cited by 44
The promise of mesenchymal stem cell therapy for acute respiratory distress syndrome
Antebi, B., Mohammadipoor, A., Batchinsky, A. I., & Cancio, L. C. (2017) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000001713 · Cited by 43
Vasculotide reduces pulmonary hyperpermeability in experimental pneumococcal pneumonia
Gutbier, B., Jiang, X., Dietert, K., Ehrler, C., Lienau, J., Slyke, P. V., Kim, H. L., Hoang, V. C., Maynes, J. T., Dumont, D., et al. (2017) · Critical Care · doi:10.1186/s13054-017-1851-6 · Cited by 44
Rodriguez, L., Mohammadipoor, A., Alvarado, L., Kamucheka, R. M., Asher, A. M., Cancio, L. C., & Antebi, B. (2019) · Cells · doi:10.3390/cells8050462 · Cited by 46
Xiansheng, H., Qin, H., Li, Y., Li, J., Fu, L., Mu-sen, L., Jiang, C. S., Yun, J., Liu, Z., Yao, F., et al. (2019) · Microbial Pathogenesis · doi:10.1016/j.micpath.2019.103846 · Cited by 45
Kandasamy, K., Escue, R., Manna, J., Adebiyi, A., & Parthasarathi, K. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00211.2014 · Cited by 41
Broquet, A. H., Jacqueline, C., Davieau, M., Besbes, A., Roquilly, A., Martin, J. P. D., Caillon, J., Dumoutier, L., Renauld, J., Heslan, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-11518-0 · Cited by 50
Zhang, H., Cui, Y., Zhou, Z., Ding, Y. P., & Nie, H. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666191204092456 · Cited by 40
Zhao, Y., Jiang, Y., Chen, L., Zheng, X., Zhu, J., Song, X., Shi, J., Li, Y., & He, W. (2020) · Journal of Thoracic Disease · doi:10.21037/jtd.2020.01.45 · Cited by 39
Oxyberberine Prevented Lipopolysaccharide‐Induced Acute Lung Injury through Inhibition of Mitophagy
Zhao, R., Wang, B., Wang, D., Wu, B., Ji, P.-Y., & Tan, D. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6675264 · Cited by 46
Therapeutic potential of plant-derived tannins in non-malignant respiratory diseases
Rajasekaran, S., Rajasekar, N., & Sivanantham, A. (2021) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2021.108632 · Cited by 41
Pulmonary surfactant as a versatile biomaterial to fight COVID-19
Herman, L., Smedt, S. C. D., & Raemdonck, K. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.11.023 · Cited by 43
Liu, D., Mao, P., Huang, Y., Liu, Y., Liu, X., Pang, X., & Li, Y. (2014) · Mediators of Inflammation · doi:10.1155/2014/469358 · Cited by 40
Lv, Y., Du, Y., Ma, S., Shi, Y., Xu, H., Deng, L., & Chen, X. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121279 · Cited by 42
The molecular mechanisms underlying anti‐inflammatory effects of galangin in different diseases
Hassanein, E. H. M., El‐Maksoud, M. S. A., Ibrahim, I. M., Abd‐alhameed, E. K., Althagafy, H. S., Mohamed, N. M., & Ross, S. A. (2023) · Phytotherapy Research · doi:10.1002/ptr.7874 · Cited by 43
Miyazaki, Y., Vieira‐de‐Abreu, A., Harris, E. S., Shah, A. M., Weyrich, A. S., Castro-Faria-Neto, H. C., & Zimmerman, G. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112770 · Cited by 43
Self-citationNew Insights into Molecular Mechanisms of Immune Complex-Induced Injury in Lung
Ward, P. A., Fattahi, F., & Bosmann, M. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00086 · Cited by 39
Zhang, X., Sun, C., Zhang, Y., Guo, H.-Z., Feng, X.-X., Peng, S.-Z., Yuan, J., Zheng, R.-B., Chen, W.-P., Su, Z., et al. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.03.057 · Cited by 41
Yin, N., Peng, Z., Li, B., Xia, J., Wang, Z., Yuan, J., Fang, L., & Lu, X. (2016) · PubMed · Cited by 42
Association of Heme Oxygenase 1 with Lung Protection in Malaria-Associated ALI/ARDS
Pereira, M. H. N., Ortolan, L. D. S., Sercundes, M. K., Debone, D., Murillo, O. J., Lima, F. A., Marinho, C. R. F., & Epiphânio, S. (2016) · Mediators of Inflammation · doi:10.1155/2016/4158698 · Cited by 39
Lü, W., Yao, X., Ouyang, P., Dong, N., Wu, D., Jiang, X., Wu, Z., Zhang, C., Xu, Z., Tang, Y., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01507 · Cited by 44
DNA Repair Interacts with Autophagy To Regulate Inflammatory Responses to Pulmonary Hyperoxia
Ye, Y., Lin, P., Zhang, W., Tan, S., Zhou, X., Li, R., Pu, Q., Koff, J. L., Dhasarathy, A., Ma, F., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601001 · Cited by 39
Immunocytometric analysis of COVID patients: A contribution to personalized therapy?
Cacciapuoti, S., Rosa, A. D., Gelzo, M., Megna, M., Raia, M., Pinchera, B., Pontarelli, A., Scotto, R., Scala, E., Scarano, F., et al. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118355 · Cited by 39
“It strongly contributes to acute respiratory distress [28] and to multiple organ dysfunction [29] syndromes typically observed in COVID patients.”
Sun, L., Liu, Y., Liu, X., Wang, R., Gong, J., Saferali, A., Gao, W., Ma, A., Ma, H., Turvey, S. E., et al. (2021) · Advanced Science · doi:10.1002/advs.202104051 · Cited by 43
Attallah, N. G. M., El-Kadem, A. H., Negm, W. A., Elekhnawy, E., El-Masry, T. A., Elmongy, E. I., Altwaijry, N., Alanazi, A. S., Al-Hamoud, G. A., & Ragab, A. E. (2021) · Pharmaceuticals · doi:10.3390/ph14121313 · Cited by 41
Silencing airway epithelial cell-derived hepcidin exacerbates sepsis-induced acute lung injury
Chen, Q. X., Song, S. W., Chen, Q. H., Zeng, C. L., Zheng, X., Wang, J. L., & Fang, X. M. (2014) · Critical Care · doi:10.1186/s13054-014-0470-8 · Cited by 38
Protein Kinase C and Acute Respiratory Distress Syndrome
Mondrinos, M. J., Kennedy, P. A., Lyons, M. M., Deutschman, C. S., & Kilpatrick, L. E. (2013) · Shock · doi:10.1097/shk.0b013e318294f85a · Cited by 42
Kinetic profiling of in vivo lung cellular inflammatory responses to mechanical ventilation
Woods, S. J., Waite, A., O'Dea, K. P., Halford, P., Takata, M., & Wilson, M. R. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00048.2015 · Cited by 43
Optimizing PEEP by Electrical Impedance Tomography in a Porcine Animal Model of ARDS
Hochhausen, N., Biener, I., Rossaint, R., Follmann, A., Bleilevens, C., Braunschweig, T. A., Leonhardt, S. K., & Czaplik, M. (2016) · Respiratory Care · doi:10.4187/respcare.05060 · Cited by 39
Cell therapy for the treatment of sepsis and acute respiratory distress syndrome
Guillamat‐Prats, R., Camprubí–Rimblas, M., Bringué, J., Tantinyà, N., & Artigas, A. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.08.28 · Cited by 38
Guillamat‐Prats, R., Puig, F., Camprubí–Rimblas, M., Herrero, R., Serrano‐Mollar, A., Gómez, M. N., Tijero, J., Matthay, M. A., Blanch, L. L., & Artigas, A. (2017) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2017.10.025 · Cited by 42
Self-citationJanga, H., Cassidy, L., Wang, F., Spengler, D., Oestern‐Fitschen, S., Krause, M., Seekamp, A., Tholey, A., & Fuchs, S. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13421 · Cited by 38
Yang, H.-M., Zhuo, J.-Y., Sun, C., Nie, J., Yuan, J., Liu, Y., Lin, R.-F., Lai, X., Su, Z., & Li, Y. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.06.029 · Cited by 38
Zhang, Q., Zhu, S., Cheng, X., Lu, C., Tao, W., Zhang, Y., William, B. C., Cao, X., Yi, S., Liu, Y., et al. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.07.025 · Cited by 40
Yin, J., Lv, L., Zhai, P., Long, T., Zhou, Q., Pan, H., Botwe, G., Wang, L., Wang, Q., Tan, L., et al. (2018) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00012.2018 · Cited by 42
Kasotakis, G., Stanfield, B. A., Haines, K., Vatsaas, C., Alger, A. R., Vaslef, S. N., Brooks, K. R., & Agarwal, S. (2021) · Journal of Critical Care · doi:10.1016/j.jcrc.2021.05.003 · Cited by 42
Bachmaier, K., Stuart, A., Singh, A., Mukhopadhyay, A., Chakraborty, S., Hong, Z., Wang, L., Tsukasaki, Y., Maienschein‐Cline, M., Ganesh, B. B., et al. (2022) · ACS Nano · doi:10.1021/acsnano.1c09762 · Cited by 40
Zheng, J., Lu, C., Ding, Y., Zhang, J., Tan, F., Liu, J., Yang, G., Wang, Y., Li, Z., Yang, M., et al. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121719 · Cited by 41
Mechanisms that determine nanocarrier targeting to healthy versus inflamed lung regions
Brenner, J. S., Bhamidipati, K., Glassman, P. M., Ramakrishnan, N., Jiang, D., Paris, A. J., Myerson, J. W., Pan, D. C., Shuvaev, V. V., Villa, C. H., et al. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.12.019 · Cited by 40
Su, D., Jiao, Z., Li, S., Yue, L., Li, C., Deng, M., Hu, L., Dai, L., Gao, B., Wang, J., et al. (2023) · Exploration · doi:10.1002/exp.20220171 · Cited by 44
Acute respiratory distress syndrome (ARDS): from mechanistic insights to therapeutic strategies
Xie, R., Tan, D., Liu, B., Xiao, G., Gong, F., Zhang, Q., Qi, L., Zheng, S., Yuan, Y., Yang, Z., et al. (2025) · MedComm · doi:10.1002/mco2.70074 · Cited by 53
“10,19,20 When severe edema develops in the alveoli, tight junctions are severely disrupted, leading to epithelial necrosis, transparent membrane formation, loss of sodium and chloride ion transport, peeling of glycosylated chemicals, increased levels of chemical factors and adhesion molecules, and…”
Asija, R., Roth, S. J., Hanley, F. L., Peng, L. F., Liu, K. D., Abbott, J. A., Zhuo, H., & Matthay, M. A. (2014) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2014.01.017 · Cited by 37
Self-citationAcute lung injury and the role of histones
Ward, P. A., & Grailer, J. J. (2014) · Translational Respiratory Medicine · doi:10.1186/2213-0802-2-1 · Cited by 37
Mulla, H., Peek, G. J., Harvey, C., Westrope, C. A., Kidy, Z., & Ramaiah, R. (2013) · Anaesthesia and Intensive Care · doi:10.1177/0310057x1304100112 · Cited by 37
Ngamsri, K., Müller, A., Bösmüller, H. C., Gamper‐Tsigaras, J., Reutershan, J., & Konrad, F. M. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601682 · Cited by 42
Pereira, M. H. N., Marinho, C. R. F., & Epiphânio, S. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00161 · Cited by 38
Liu, S., Yue, Y., Pan, P., Zhang, L., Su, X., Li, H., Li, H., Li, Y., Dai, M., Li, Q., et al. (2018) · Inflammation · doi:10.1007/s10753-018-0903-7 · Cited by 40
Kim, Y.-M., Krantz, S., Jambusaria, A., Tóth, P. T., Moon, H., Gunarathna, I., Park, G. Y., & Rehman, J. (2021) · Nature Communications · doi:10.1038/s41467-021-23047-6 · Cited by 43
Neutrophils as an emerging therapeutic target and tool for cancer therapy
Subhan, M. A., & Torchilin, V. P. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119952 · Cited by 38
Glycyrrhizin mitigates acute lung injury by inhibiting the NLRP3 inflammasome in vitro and in vivo
Wang, J., Ren, C., Bi, W., & Batu, W. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115948 · Cited by 41
Spred-2 Deficiency Exacerbates Lipopolysaccharide-Induced Acute Lung Inflammation in Mice
Xu, Y., Ito, T., Fushimi, S., Takahashi, S., Itakura, J., Kimura, R., Sato, M., Mino, M., Yoshimura, A., & Matsukawa, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108914 · Cited by 35
Xu, Y., Zhang, R., Li, C., Yin, X., Lv, C., Wang, Y., Zhao, W., & Zhang, X. (2015) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12138 · Cited by 36
Lalu, M. M., Moher, D., Marshall, J. C., Fergusson, D. A., Mei, S. H. J., Macleod, M. R., Griffin, G., Turgeon, A. F., Rudnicki, M. A., Fishman, J., et al. (2014) · Systematic Reviews · doi:10.1186/2046-4053-3-48 · Cited by 41
Diverse Profiles of Ricin-Cell Interactions in the Lung Following Intranasal Exposure to Ricin
Sapoznikov, A., Falach, R., Mazor, O., Alcalay, R., Gal, Y., Seliger, N., Sabo, T., & Kronman, C. (2015) · Toxins · doi:10.3390/toxins7114817 · Cited by 37
Therapeutic time window for angiotensin‐(1–7) in acute lung injury
Supé, S., Kohse, F., Gembardt, F., Kuebler, W. M., & Walther, T. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13462 · Cited by 36
Ware, L. B., Zhao, Z., Koyama, T., Brown, R. M., Semler, M. W., Janz, D. R., May, A. K., Fremont, R. D., Matthay, M. A., Cohen, M. J. M., et al. (2017) · Trauma Surgery & Acute Care Open · doi:10.1136/tsaco-2017-000121 · Cited by 42
Self-citationLv, J., Zeng, J., Guo, F., Li, Y., Xu, M., Cheng, Y., Zhang, L., Cai, S., Chen, Y., Zheng, Y., et al. (2018) · Respiratory Research · doi:10.1186/s12931-018-0729-8 · Cited by 39
Sim, T. Y., Harith, H. H., Tham, C. L., Hashim, N. F. M., Shaari, K., Sulaiman, M. R., & Israf, D. A. (2018) · Molecules · doi:10.3390/molecules23061355 · Cited by 36
Yu, J., Ni, L., Zhang, X., Zhang, J., Abdel-Razek, O. A., & Wang, G. (2018) · Shock · doi:10.1097/shk.0000000000001244 · Cited by 36
Wound healing and fibrosis: current stem cell therapies
Jones, R. E., Foster, D. S., Hu, M. S.-M., & Longaker, M. T. (2019) · Transfusion · doi:10.1111/trf.14836 · Cited by 46
“Mortality from ARDS ranges from 20% to 40%.(67) Studies utilizing MSCs for ARDS have shown good therapeutic tolerance,(68) as well as improved recovery from ventilator-associated pulmonary injury,(69) decreased pulmonary edema, and increased presence of peripheral regulatory T cells.”
BackgroundHe, J., Qi, D., Tang, X., Deng, W., Deng, X., Zhao, Y., & Wang, D. (2019) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-019-0154-0 · Cited by 38
Inflammation without Vascular Leakage. Science Fiction No Longer?
Filewod, N. C. J., & Lee, W. L. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201905-1011cp · Cited by 35
A Blood Exosomal miRNA Signature in Acute Respiratory Distress Syndrome
Parzibut, G., Henket, M. A., Moermans, C., Struman, I., Louis, E. J., Malaise, M., Louis, R. E., Misset, B., Njock, M., & Guiot, J. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.640042 · Cited by 38
Acute Lung Injury and Fibrosis in a Baboon Model of Escherichia coli Sepsis
Keshari, R. S., Silasi‐Mansat, R., Zhu, H., Popescu, N. I., Peer, G. T., Chaaban, H., Lambris, J. D., Polf, H. D., Lupu, C., Kinasewitz, G. T., et al. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0219oc · Cited by 36
Apocynin ameliorates endotoxin-induced acute lung injury in rats
Abdelmageed, M. E., El‐Awady, M. S., & Suddek, G. M. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.12.006 · Cited by 37
Wu, Y., Zhang, Y., Tang, X., Ye, S., Shao, J., Tu, L., Pan, J., Chen, L., Liang, G., & Yin, L. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02237-y · Cited by 35
Liu, Y., Wang, X., Chen, Y., Zhou, L., Wang, Y., Li, L., Wang, Z., & Li, Y. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155562 · Cited by 40
Wang, G., Ma, X., Huang, W., Wang, S., Lou, A., Wang, J., Tu, Y., Cui, W., Zhou, W., Zhang, W., et al. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02597-z · Cited by 42
He, H., Liu, L., Chen, Q., Cai, S., Han, J., Hu, S., Chun, P., Yang, Y., Guo, F., Huang, Y., et al. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24794 · Cited by 35
Luo, J. F., Wang, M. Z., Zhu, H., Liang, B., Liu, D., Peng, X., Wang, R., Li, C., He, C.-Y., & Liang, Z. (2014) · Respirology · doi:10.1111/resp.12383 · Cited by 38
Age-Related Changes in Immunological and Physiological Responses Following Pulmonary Challenge
Miller, E. J., & Linge, H. M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061294 · Cited by 36
The Basic Science and Molecular Mechanisms of Lung Injury and Acute Respiratory Distress Syndrome
Aranda‐Valderrama, P., & Kaynar, A. M. (2017) · International Anesthesiology Clinics · doi:10.1097/aia.0000000000000177 · Cited by 39
Shah, D., Das, P., Alam, M. A., Mahajan, N., Romero, F., Shahid, M., Singh, H., & Bhandari, V. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0194oc · Cited by 35
“Acute respiratory distress syndrome (ARDS) is a severe form of respiratory failure that develops abruptly in patients with other serious medical conditions, such as sepsis, major trauma and pneumonia, and many other lung-related disease conditions (1, 2).”
RetractedPropofol inhibits endogenous formyl peptide-induced neutrophil activation and alleviates lung injury
Chen, C., Tsai, Y., Huang, W., Chang, S.-H., & Hwang, T. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.09.048 · Cited by 35
“Despite considerable progress in elucidating the mechanisms of sepsis and sepsis-associated ALI as well as the development of novel intervention therapies in ICUs, sepsis and sepsis-induced ALI remain leading causes of mortality in critically ill patients [49].”
BackgroundLiu, H., Hao, J., Wu, C., Liu, G., Wang, X., Yu, J., Liu, Y. S., & Zhao, H. (2019) · Medical Science Monitor · doi:10.12659/msm.917406 · Cited by 35
Neurogenic pulmonary edema following acute stroke: The progress and perspective
Zhao, J., Xuan, N., Cui, W., & Tian, B. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110478 · Cited by 44
Wang, Y., Xue, L., Wu, Y., Zhang, J., Dai, Y., Li, F., Kou, J., & Zhang, Y. (2021) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgaa039 · Cited by 37
Sun, W., Wu, W., Jiang, N., Ge, X., Zhang, Y., Han, J., Guo, X., Zhou, L., & Yang, H. (2022) · Viruses · doi:10.3390/v14030452 · Cited by 31
Endothelial Progenitor Cells in the Host Defense Response
Shi, X., Seidle, K. A., Simms, K. J., Dong, F., Chilian, W. M., & Zhang, P. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108315 · Cited by 44
Current Knowledge of Th22 Cell and IL-22 Functions in Infectious Diseases
Zhang, K., Chen, L., Zhu, C., Zhang, M., & Liang, C.-Z. (2023) · Pathogens · doi:10.3390/pathogens12020176 · Cited by 31
Gonçalves-de-Albuquerque, C. F., Burth, P., Silva, A. R., de Moraes, I. M., Oliveira, F. D. J., Santelli, R. E., Freire, A. S., Bozza, P. T., Younes-Ibrahim, M., de Castro-Faria-Neto, H., et al. (2013) · Journal of Inflammation · doi:10.1186/1476-9255-10-34 · Cited by 35
“The initial lesion in ARDS is an increase in the alveolar capillary permeability to plasma proteins, which leads to an interstitial and alveolar edema [3,5].”
BackgroundKinin B1 Receptor Antagonist BI113823 Reduces Acute Lung Injury*
Nasseri, S., Gurusamy, M., Jung, B., Lee, D., Khang, G., Doods, H. N., & Wu, D. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000001268 · Cited by 35
Lung regeneration: diverse cell types and the therapeutic potential
Chen, Y., Li, Z., Ji, G., Wang, S., Mo, C., & Ding, B. (2024) · MedComm · doi:10.1002/mco2.494 · Cited by 39
Differences in degree, differences in kind
Howard, B. M., Kornblith, L. Z., Hendrickson, C. M., Redick, B. J., Conroy, A. S., Nelson, M. F., Callcut, R. A., Calfee, C. S., & Cohen, M. J. M. (2015) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000000583 · Cited by 37
Metadata
- Authors
- Matthay, M. A., Ware, L. B., & Zimmerman, G. A.
- Affiliations
- University of California, San Francisco (US)
- Vanderbilt University (US)
- University of Utah (US)
- Corresponding author
- Matthay, Michael A.
- Venue
- Journal of Clinical Investigation
- Published
- 2012-08-01
- Volume
- 122
- Issue
- 8
- Pages
- 2731-2740
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3408735
- OpenAlex
- W3020992950
- Cited by
- 1,706
- References
- 154
- Citations by year
- 2026: 51 · 2025: 74 · 2024: 116 · 2023: 108 · 2022: 136 · 2021: 158 · 2020: 174 · 2019: 126 · 2018: 128 · 2017: 146 · 2016: 128 · 2015: 132 · 2014: 132 · 2013: 84 · 2012: 10
- FWCI
- 19.05
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Heart Association
- National Institutes of Health
- U.S. Public Health Service (R01A1087674, P01 A1053194)
- University of California, San Francisco
- National Heart, Lung, and Blood Institute (U01HL108713, HL 088263, R01HL088263, R37HL044525, K24HL103836, HL103836, U01HL10871301, 5R37HL44525-23, R01HL091754, RC2HL101779, RC1HL100121, R01HL051854, R01HL101779, R37HL051856)
- National Institute of Allergy and Infectious Diseases
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Respiratory Support and Mechanisms
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Neonatal Respiratory Health Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Keywords
- acute respiratory distress syndrome, acute respiratory failure, multiple organ failure, pulmonary edema, arterial hypoxemia, hypercapnia, pathogenesis, lung injury, lung repair, lung-protective ventilation, pneumonia, sepsis, aspiration, trauma (physical injury), genetic factors
- MeSH terms
- Clinical Trials as Topic, Humans, Permeability, Respiratory Distress Syndrome, Signal Transduction, Pneumonia, Ventilator-Associated, Acute Lung Injury
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.